Updated:
Biosense Webster
Biosense Webster develops and manufactures medical devices for treating cardiac arrhythmias. The company offers catheters and systems for mapping and ablating...
Overview
Biosense Webster develops and manufactures medical devices for treating cardiac arrhythmias. The company offers catheters and systems for mapping and ablating heart tissue to address conditions like atrial fibrillation and ventricular tachycardia. Its products are used by healthcare professionals in cardiology and electrophysiology.
General information
Firm type
other
Year founded
1995
Location
Region
North America
Country
United States
City
Irvine
Corporate office
Irvine, CA, United States
Sector focus
Frequently asked questions
Does Biosense Webster have independent decision-making or report to Johnson & Johnson?
Biosense Webster operates as a business unit within J&J's MedTech segment, with its leadership reporting to J&J's corporate structure. Strategic decisions such as acquisitions, pricing, and large capital expenditures require J&J board approval. The firm has no separate governance or capital allocation autonomy.
What scale does Biosense Webster operate at?
While J&J does not disclose subsidiary-level revenue, Biosense Webster's over 3 million procedures performed and 7,000 employees place it among the largest electrophysiology device companies globally. J&J's MedTech segment, which includes Biosense Webster, reported $27.4 billion in 2023 sales (per J&J 10-K, February 2024).
Where are Biosense Webster's major R&D and manufacturing sites?
The corporate headquarters is in Irvine, California, with additional R&D and manufacturing operations in Israel, including a facility in Yokneam. A $400 million expansion at the Irvine site was announced in 2024 to increase catheter production capacity.
What competitive advantage does Biosense Webster have?
The company holds over 2,000 patents and its CARTO mapping platform is the gold standard in electrophysiology. Being part of J&J gives it a massive distribution network, clinical research infrastructure, and regulatory expertise — but it also means slower independent innovation cycles compared to smaller startups.
How does Biosense Webster make money?
Revenue comes from selling disposable electrophysiology catheters, mapping systems, and capital equipment to hospitals and electrophysiology labs globally. The business model is volume-driven — per-procedure catheter usage generates recurring revenue, supplemented by capital equipment sales of the CARTO platform.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: